None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed with acute ischemic stroke who presented to participating medical institutions 2. Patients enrolled in the main multicenter cohort study using Heuron StroCare Suite™ 3. Patients who underwent imaging studies (e.g., PET-CT or SPECT) 4. Patients with available clinical and imaging data for analysis
Exclusion criteria
Exclusion criteria: 1. Patients who did not undergo imaging studies 2. Patients with insufficient clinical or imaging data for analysis 3. Patients without consent for participation (if applicable) 4. Patients deemed inappropriate for inclusion by the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison of brain metabolic function before and after AI solution application;Comparison of cerebral blood flow status before and after AI solution application | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparison of regional brain metabolic function before and after AI solution application;Comparison of brain metabolic function according to time from symptom onset to reperfusion treatment initiation;Comparison of brain metabolic function according to time from hospital arrival to reperfusion treatment initiation;Comparison of brain metabolic function according to time from stroke team activation to reperfusion treatment initiation;Comparison of cerebral blood flow status according to time from symptom onset to reperfusion treatment initiation;Comparison of cerebral blood flow status according to time from hospital arrival to reperfusion treatment initiation;Comparison of cerebral blood flow status according to time from stroke team activation to reperfusion treatment initiation;Comparison of early neurological deterioration or improvement according to brain metabolic function;Comparison of 3-month prognosis (mRS) according to brain metabolic function;Comparison of early neurological deterioration or improvement according to cerebral blood flow status;Comparison of 3-month prognosis (mRS) according to cerebral blood flow status | — |
Countries
Korea, Republic of
Contacts
Chonnam National University Hospital